Cyto-Sen Therapeutics, Inc. is a biopharmaceutical company bringing innovation to natural killer (NK) cell therapy by generating large numbers of highly-active natural killer cells with its particle-based “expansion and activation” process. Born from the intersection of cellular immunotherapy and nanotechnology, Cyto-Sen’s NK cell therapy harnesses the power of the immune system to treat cancer.
